THE BASIC PRINCIPLES OF HYPERBARIC CHAMBER BURNS

View Whole Prescribing Facts OPDIVO® (nivolumab) is indicated for the treatment of Grownup patients with classical Hodgkin lymphoma (cHL) which has relapsed or progressed following autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin or just after 3 or more lines of systemic therapy that features autologous HSCT.be mad